Krabbe disease – Medical Marijuana

Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis

By admin| 2016-07-06T06:38:05+01:00 July 6th, 2016|

The Endocannabinoid System Is Dysregulated in Multiple Sclerosis and in Experimental Autoimmune Encephalomyelitis

By admin| 2016-07-06T06:37:19+01:00 July 6th, 2016|

The endocannabinoid system as a target for the treatment of neurodegenerative disease

By admin| 2016-07-06T06:36:37+01:00 July 6th, 2016|

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection

By admin| 2016-07-06T06:35:58+01:00 July 6th, 2016|

Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor

By admin| 2016-07-06T06:34:42+01:00 July 6th, 2016|

CB2 cannabinoid receptors as an emerging target for demyelinating diseases- from neuroimmune interactions to cell replacement strategies

By admin| 2016-07-06T06:33:54+01:00 July 6th, 2016|

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

By admin| 2016-07-06T06:32:13+01:00 July 6th, 2016|

Cannabinoids as novel anti-inflammatory drugs

By admin| 2016-07-06T06:31:28+01:00 July 6th, 2016|